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Letters to the Editorand the constant improvements in re-
sults during the last 50 years are also
due to the different ECC techniques
that were developed during this long
period. At many institutions, off-
pump CABG represents about 20%
to 30% of cardiac surgical procedures.
The remainder of the operations are
performed with ECC. We, therefore,
believe that further improvement of
ECC could improve overall results.
In fact, according to our results1 and
the results of Puelher and colleagues,
with the MECC is possible to perform
a complete myocardial revasculariza-
tion with the same systemic, cardiac,
and clinic results observed with off-
pump CABG. Moreover, we think
that this system could be safely ex-
tended to other, more complex cardiac
operations, such as the Bentall opera-
tion, aortic valve replacement, ascend-
ing aortic replacement, and mitral
valve surgery.
Recently, we used the MECC in
the cases of 2 patients with a large
thrombus of the inferior vena cava as a
complication of a left renal tumor.
Urologists referred the patients to us,
and they preferred to perform the oper-
ation during a period of circulatory
arrest. We decide to use the MECC for
both patients, with the aim of reducing
the bleeding. Both cooling and re-
warming phases were done with the
MECC. Some minutes before the start
of arrest (body temperature 20C), the
activated clotting time (ACT) was in-
creased to 480 seconds, and the blood
was drained from a different cardiot-
omy added to the circuit. We observed
that blood loss and hemostasis were
easy to manage in both patients with
2 large surgical incisions, in the chest
and abdomen. Both patients were dis-
charged alive.
Maintaining the ACT around 200 to
300 seconds during the MECC proce-
dure is one of the keys of the system.
We have usually used the same ACT
target reported by Puehler and col-
leagues, which is similar to the ACT
of our patients operated on off-pump234 The Journal of Thoracic and Cand is statistically lower than that our
patients operated on with ECC. More-
over, in an ongoing prospective ran-
domized trial, we found that patients
operated on with standard ECC had
more postoperative bleeding and
need for more red blood cell transfu-
sions than did those in MECC and
off-pump CABG groups.
The concept of a miniaturized sys-
tem means less biologic and metabolic
invasiveness, or in other words, as
Puehler and colleagues intend, less
hemodilution, better renal and pulmo-
nary preservation, less coagulative
disorder, and less inflammatory re-
sponse. Last but not least, in an era in
which coronary surgery on high-risk
patients is increasing and many sur-
geons are afraid to use standard ECC,
complete myocardial revasculariza-
tion with the MECC could be a valid
option to achieve good clinical out-
come.
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PERFUSION MAY REDUCE
PULMONARY INJURY DURING
CARDIOPULMONARY BYPASS
To the Editor:
During cardiac surgery with cardio-
pulmonary bypass (CPB), the surgeon
is assured that all organs are perfused
and/or protected. The heart—lung ma-
chine provides perfusion to all organs
while the heart is either cardioplegically
arrested or perfused.1 One assumes that
the lungs are perfused, although pulmo-
nary artery blood flow, themajor source
of blood supply to the lungs, ceases.
Discontinuation of pulsatile flow and
low mean pressures further accentuate
decreased bronchial artery flow. The
lung is the ‘‘target’’ organ, especially
during prolonged CPB. Severe pulmo-
nary dysfunction, manifested as poor
gas exchange, pulmonary edema, and
prolonged need for artificial ventilation,
are consequences.
Imura and associates2 correlated
low-frequency mechanical ventilation
during CPB in pigs with suppression
of ischemic derangements in tissue
metabolism and histopathologic
changes in the lungs. The technique
appears simple and safe and could po-
tentially be used in clinical practice.2
Why have cardiac surgeons not per-
fused/ventilated the lungs during
CPB? Should they? The majority of
surgeons were not trained in lung per-
fusion and most would say that, for
short pump runs, the results are excel-
lent. Perfusion of the lungs leads to
blood in the operative field and
decreases surgical precision. Lung
perfusion does not necessarily have
to be continuous. Intermittent lung
perfusion (pneumoplegia) could be
instituted at the same time that the
surgeon administers intermittent cold
cardioplegic arrest. This would elimi-
nate the problem of visualization and
blood in the operative field. A compro-
mise, as suggested by Imura and asso-
ciates,2 is simply to ventilate the lungs
in the hope that some gas exchange
wouldoccur.Low-frequencyventilation2
FIGURE 1. ETCO2 recorded in a patient during valve replacement. A, Before cardiopulmonary bypass (CPB) (ETCO2¼ 22 mm Hg). B, During CPB
(ETCO2¼ 12 mm Hg). C, After CPB (ETCO2¼ 33 mm Hg). PAW, Peak airway pressure; PEEP, peak expiratory airway pressure; RR, respiratory rate;
MV,minute ventilation; TVexp, expiratory tidal volume; ETCO2, end-tidal carbon dioxide; ETO2, end-tidal oxygen; FICO2, inspired carbon dioxide fraction;
FIO2, inspired oxygen fraction; Ppeak, peak pressure.
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Letters to the Editoris beneficial to the lungs of pigs under
conditions of CPB. Can that be extrap-
olated to man?
An important issue to be addressed
is whether lung ventilation/perfusion,
during conditions of CPB, promotes
gas exchange. We3 have performed
all valve procedures with the heart
beating, perfused simultaneously ante-
gradely and retrogradely with warm
blood, and with the lungs ventilated/
perfused during the cardiac procedure,
in an effort to decrease ischemia–
reperfusion injury. End-tidal carbon
dioxide (ETCO2), a measurement of
pulmonary blood flow and cardiac
output, was continuously monitored.
ETCO2 provides a noninvasive esti-
mate of cardiac output, through the
ratio of change in ETCO2 partial pres-
sure and CO2 elimination after a brief
period of partial rebreathing.4 Expired
CO2 is assessed by a noninvasive CO2
monitor that integrates the differential
CO2 Fick partial rebreathing tech-
nique.5 Preliminary work shows that
ETCO2 is an excellent indicator of
lung perfusion, but its clinical value re-
mains unclear. ETCO2 continued to be
present once CPB was initiated and
was unchanged throughout the opera-
tions. An example of one valve case
is shown in Figure 1. Perfusion/venti-
lation of the lungs did not interfere
with the operation.
Recently, we received institutional
review board approval for a prospec-
tive randomized clinical trial to evalu-
ate lung perfusion/ventilation during
CPB. Results will be forthcoming.
On the basis of initial experience by
Imura and associates2 in pigs and our
own experience with humans, in long
and complicated procedures, or in
patients with pre-existing pulmonary
diseases, lung perfusion/ventilation is
recommended. Potentially, lung injury
can be decreased in these patients.
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We thank Dr Macedo and col-
leagues for their interest in our study
on low-frequency ventilation during
cardiopulmonary bypass (CPB) that
was recently published in the Journal.1
They share our interest in lung injury
during cardiac surgery and how to pre-
vent it. We believe this is relevant to
current practice with an ever-increas-
ing population of high-risk patients.
The rationale beyond our interest in
lung injury is based on the simple
observation that in current clinical
practice, once CPB is instituted, the
patient’s lungs are disconnected from
the ventilator and left open to the air,
fully collapsed and poorly perfused
for the duration of CPB. Our report
showed significant ischemic damage
and atelectasis in the collapsed lungs
during and after CPB, and these were
improved by using low-frequency
ventilation during CPB.1 Althoughardiovascular Surgery c January 2009the underlying mechanisms are still
unclear, there have been reports sug-
gesting that ventilation during CPB
may reduce damage in the lungs.2
We have taken this forward and are
now about to start a large clinical trial
to assess low-frequency ventilation in
clinical practice.
The issue of pulmonary perfusion
during cardiac surgery is an interesting
one. Current practice is based on the as-
sumption that bronchial blood supply is
sufficient for lung protection during
CPB.3 Yet, during cardiac surgery the
bronchial circulation (only 1%–2% of
the cardiac output) is jeopardized by
CPB and surgery-related factors, includ-
ing lungcollapse, internal thoracic artery
harvesting, aortic manipulation, hypo-
thermia, and loss of pulsatile flow. Sche-
lensak and colleagues4 showed that
there is significant decrease in bronchial
arterial flow during the initial phase of
total CPB and that flow remains low un-
til the end of CPB, returning to normal
by 60 minutes of reperfusion.
This highlights the importance that
pulmonary circulation may have for
alveolar oxygenation, which is also
supported by the observation that dur-
ing lung transplantation surgery the
bronchial arteries rarely are recon-
nected without obvious lung ischemia.
Pulmonary artery perfusion is an
obvious potential intervention to pre-
vent lung ischemia. Along with Dr
Macedo and colleagues, we are cur-
rently focusing on this in ongoing ex-
perimental research.
Others have suggested that ventila-
tion during CPB can reduce lung
injury.4,5 In our view, the safety, effi-
cacy, and surgical practicality of pulmo-
nary perfusion during CPB remains to
be proven beyond any doubt before
establishing it in clinical practice. Also,
there is still a lot of research to undertake
to ascertain themechanistic insights, the
dominance of ventilation versus perfu-
sion or vice versa as a protective inter-
vention, and the best route or mode of
delivery of pulmonary perfusion.
